Drug Profile
Formoterol/fluticasone inhalation capsules - Sun Pharmaceutical Industires
Alternative Names: AvessaLatest Information Update: 05 Feb 2019
Price :
$50
*
At a glance
- Originator Ranbaxy Laboratories
- Class Antiallergics; Antiasthmatics; Ethanolamines; Glucocorticoids; Small molecules
- Mechanism of Action Beta 2 adrenergic receptor agonists; Steroid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Asthma
Most Recent Events
- 05 Feb 2019 Chemical structure information added
- 25 Mar 2015 Ranbaxy Laboratories has been acquired by Sun Pharmaceutical Industries
- 20 Oct 2008 Ranbaxy Laboratories has been acquired by Daiichi Sankyo Company